Nkarta Therapeutics

OverviewSuggest Edit

Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer. The company combines its NK platform technology with cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of tumor targets, and improve persistence for sustained activity in the body.

TypePrivate
Founded2015
HQSouth San Francisco, CA, US
Websitenkartatx.com

Latest Updates

Employees (est.) (Sept 2021)117(+3%)
Job Openings23
Cybersecurity ratingDMore

Key People/Management at Nkarta Therapeutics

Paul Hastings

Paul Hastings

Chief Executive Officer
Ralph Brandenberger

Ralph Brandenberger

Vice President, Technical Operations
Alicia Hager

Alicia Hager

Chief Legal Officer
Nadir Mahmood

Nadir Mahmood

Chief Financial and Business Officer
Kanya Rajangam

Kanya Rajangam

Chief Medical Officer
James Trager

James Trager

Chief Scientific Officer
Show more

Nkarta Therapeutics Office Locations

Nkarta Therapeutics has an office in South San Francisco
South San Francisco, CA, US (HQ)
6000 Shoreline Ct #102
Show all (1)

Nkarta Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2015

Nkarta Therapeutics total Funding

$125 m

Nkarta Therapeutics latest funding size

$114 m

Time since last funding

2 years ago

Nkarta Therapeutics investors

Nkarta Therapeutics's latest funding round in September 2019 was reported to be $114 m. In total, Nkarta Therapeutics has raised $125 m
Show all financial metrics

Nkarta Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

D

69/100

SecurityScorecard logo

Nkarta Therapeutics Online and Social Media Presence

Embed Graph

Nkarta Therapeutics News and Updates

Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term

SOUTH SAN FRANCISCO, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced that Chief Executive Officer Paul Hastings has been elected as the Chair of the Biotechn…

Nkarta Therapeutics Frequently Asked Questions

  • When was Nkarta Therapeutics founded?

    Nkarta Therapeutics was founded in 2015.

  • Who are Nkarta Therapeutics key executives?

    Nkarta Therapeutics's key executives are Paul Hastings, Ralph Brandenberger and Alicia Hager.

  • How many employees does Nkarta Therapeutics have?

    Nkarta Therapeutics has 117 employees.

  • Who are Nkarta Therapeutics competitors?

    Competitors of Nkarta Therapeutics include Lyell, Socium Therapeutics and Autonomous Therapeutics.

  • Where is Nkarta Therapeutics headquarters?

    Nkarta Therapeutics headquarters is located at 6000 Shoreline Ct #102, South San Francisco.

  • Where are Nkarta Therapeutics offices?

    Nkarta Therapeutics has an office in South San Francisco.

  • How many offices does Nkarta Therapeutics have?

    Nkarta Therapeutics has 1 office.